Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
50
NMPA:50
Drug Approvals
Sodium Chloride Injection
- Product Name
- 氯化钠注射液
- Approval Number
- 国药准字H20247137
- Approval Date
- Jun 25, 2024
NMPA
Sodium Chloride Injection
- Product Name
- 氯化钠注射液
- Approval Number
- 国药准字H20247046
- Approval Date
- Mar 21, 2024
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20183402
- Approval Date
- Sep 27, 2023
NMPA
Brimonidine Tartrate and Timolol Maleate Eye Drops
- Product Name
- 溴莫尼定噻吗洛尔滴眼液
- Approval Number
- 国药准字H20223688
- Approval Date
- Sep 20, 2022
NMPA
Adenosine Disodium Triphosphate Sodium Chloride Injection
- Product Name
- 新隆宁
- Approval Number
- 国药准字H20052584
- Approval Date
- Jul 18, 2022
NMPA
Sodium Ferulate and Sodium Chloride Injection
- Product Name
- 亿博特
- Approval Number
- 国药准字H20051428
- Approval Date
- Jul 18, 2022
NMPA
Lysine Hydrochloride and Glucose Injection
- Product Name
- 思弗提
- Approval Number
- 国药准字H20050211
- Approval Date
- Jul 17, 2022
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20227045
- Approval Date
- Mar 30, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found